AstraZeneca coronavirus vaccine clinical trials resume in U.K. after pause over safety concerns


AstraZeneca’s building in Luton, Britain.

Tim Ireland | Xinhua News Agency | Getty Images

Phase three trials for AstraZeneca’s coronavirus vaccine have resumed in the U.K. after they were halted earlier this week over safety concerns, the company announced Saturday.

AstraZeneca said it received confirmation from the United Kingdom’s Medicines Health Regulatory Authority that it was safe to resume clinical trials. The company declined to disclose medical information about the pause of the trial. 

This is breaking news. Check back here for updates.



Source link

Discover

Sponsor

Latest

Palantir direct listing reference price: $7.25, says NYSE

Palantir Technologies CEO Alex Karp arrives at the "Tech for Good" Summit in Paris, France May 15, 2019.Charles Platiau | ReutersThe New York...

CDC Posted Test Guideline Without Scientific Review

Sept. 18, 2020 -- U.S. Health and Human Services (HHS) officials wrote a controversial recommendation about COVID-19 testing that appeared on the U.S....

2022 Mitsubishi Eclipse Cross previewed in teaser image

Mitsubishi's long-promised new models are right around the corner. It released a dark image to preview the 2022 Eclipse Cross, which will boast...

Despite Trump’s move, markets are still expecting stimulus and a sizable one if Democrats sweep

A man walks near the New York Stock Exchange (NYSE) on August 31, 2020 at Wall Street in New York City.Angela Weiss |...

2021 Tesla Model 3 Packs More Range, Interior and Exterior Improvements

Even though the Tesla Model 3 has only been with us for a few model years, it is still a work in progress...